Redx Pharma Share Discussion Threads

[knitcraft] 15/9/2021 10:45

Completely different management these days. Seem to be doing a great job. Statement next week is expected to be very positive. Tremendous potential to make a difference to Cancer and Fibrosis treatment. It will all take time to materialise but is well worth the wait as a shareholder.

[latifs100] 14/9/2021 21:16

gutted sold at 70p

[chesty1] 14/9/2021 10:22

Well done Wapper!

[macmoss] 14/9/2021 10:22

I’m being greedy, average buy price is 53p but I’ll stick with it.

[wapper] 14/9/2021 10:21

CHESTY ....Look at the increase since my post on 6th. Over 50% . I rest my case .Good luck to you and all holders here. I love the Company but sometimes we have to make difficult decisions. Buying is easy : selling is always harder as we all know.

[chesty1] 14/9/2021 10:15

Wapper6 Sep '21 - 08:27 - 489 of 497 0 0 0 Great day so far. Still way undervalued Wapper14 Sep '21 - 09:55 - 496 of 497 0 0 0 I'm out and very happy with a 3 bagger. WOW!!!!

[wapper] 14/9/2021 09:58

Added to my KOD holding with some of REDX cash

[wapper] 14/9/2021 09:55

I'm out and very happy with a 3 bagger. Just feel it's possibly getting ahead of itself now but it's only a gut feel so no advice intended. Sorry to see it leave my portfolio and will keep on watch list

[demark] 14/9/2021 09:47

i have copied this from another bb! 05/09/21 The Sunday Times article mentions Redx's BTK inhibitor that was sold to Loxo Oncology - the first of Redx's molecules to be monetised. Loxo was subsequently bought by Eli Lilly and Redx's BTK inhibitor now goes under the name of Pirtobrutinib. Lilly have been pressing ahead with clinical trials and Pirtobrutinib is now regarded as one of the most promising candidates in their pipeline. Only a few days ago, really impressive phase I/II results in lymphoma were presented at the 2021 Pan Pacific Lymphoma Conference with an overall MCL response rate of 52% and a complete response rate of 25%. These rates were achieved in patients who had been heavily pretreated and failed on other therapies, including other BTK inhibitors, CAR-T and stem cell transplants. Even higher responses were seen in other types of lymphoma. Pirtobrutinib is now undergoing phase III studies. The point is that industry will be aware of the quality of the molecules coming out of Redx's labs and the success to date of Pirtobrutinib will not be lost on any who may be watching the progress of RXC004 - phase I clinical trial results are due to be presented at ESMO in a couple of weeks. https://www.onclive.com/view/pirtobrutinib-exhibits-promising-efficacy-in-heavily-pretreated-mcl-and-other-non-hodgkin-lymphomas

[knitcraft] 10/9/2021 19:08

Any update amrish? I think we would all appreciate your views on the future of Redx and it’s share price

[amrishbhim] 06/9/2021 10:27

That sucks on all top three raise shares

[kevinroe] 06/9/2021 09:56

Dnt be impaled in this

[latifs100] 06/9/2021 08:50

up 28%, but spread 4p

[wapper] 06/9/2021 08:27

Great day so far. Still way undervalued

[wapper] 05/9/2021 14:33

Thanks Knitcraft. Good article. £1.35 price target

[knitcraft] 05/9/2021 12:28

A very good appraisal of Redx in today’s Sunday Times Business Section. Finishes off with a “buy” recommendation. Worth a read..

[wapper] 02/9/2021 07:57

Welcome news this morning along with a reminder of just how big this could be .Happy to hold

[knitcraft] 30/3/2021 12:33

Looks like RedX is coming good for investors. Anyone who can be bothered to look more deeply into what has been achieved in the last 12 months will realise what an opportunity presents itself. They are on the cusp of tremendous results to benefit cancer and fibrosis patients. There are only 8% of the shares available in the market. Any positive news from just one of their research projects will transform RedX.They are presenting to a conference in the US in 10 days. Look into the background of the team for any reassurance on what they bring to the company. Funding is in place for two years of funding at the end of which the share price could be many multiples of today's breakout figure of 75.

[wapper] 27/1/2021 07:42

All on track. Still see this as a bagger in waiting. Happy to hold and accumulate on any weakness . Might be an interesting day here. GLAH

[supercity] 27/1/2021 07:26

Looks like they are expecting a transformational year especially if milestones are hit and they start receiving the payments from Glaxo (up to 360m) and Jazz (up to 400m) which were agreed last year.

[wapper] 26/1/2021 13:11

Results due tomorrow

[knitcraft] 23/12/2020 13:44

Looks like a reversal today after Lisa Anson's purchase. Now the issue of new shares is out of the way and should begin to retrace up to the nineties soon. Fully funded for two years with other payments already in the pipeline. Confident this will reward investors in the next couple of years.

[stevieweebie2] 03/12/2020 08:56

spread wider than a hookers legs aint helping I can tell you.